PLBL:NASDAQPolibeli Group Ltd Analysis
Data as of 2026-05-21 - not real-time
$7.30
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The 20‑day SMA sits below both the 50‑day and 200‑day SMAs, confirming a bearish trend, while the RSI hovers around the neutral midpoint, offering no clear momentum bias. The MACD line is negative but the histogram has turned positive, indicating a tentative bullish signal that conflicts with the broader downtrend. Price is trading near a recent support level with a clear resistance ceiling higher up, and volume is on an upward trajectory, suggesting heightened trader interest despite the bearish price action.
Fundamental backdrop: Revenue has surged dramatically, yet margins are deeply negative and cash flow remains in the red, leading to a price that is far above sales and book value. The company carries modest debt, but its book value per share is negative, and there is no dividend to speak of. Volatility is extreme, beta is slightly negative, and market sentiment is in an “Extreme Greed” phase, all of which amplify the risk of a sharp correction.
Fundamental backdrop: Revenue has surged dramatically, yet margins are deeply negative and cash flow remains in the red, leading to a price that is far above sales and book value. The company carries modest debt, but its book value per share is negative, and there is no dividend to speak of. Volatility is extreme, beta is slightly negative, and market sentiment is in an “Extreme Greed” phase, all of which amplify the risk of a sharp correction.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish SMA crossover
- Price near support with limited upside
- High volatility and extreme greed sentiment
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth offset by negative margins
- Increasing trading volume
- Continued cash‑flow deficits
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential for operational turnaround if margins improve
- Persistent negative book value and earnings
- Sector cyclicality and exposure to multiple geographies
Key Metrics & Analysis
Financial Health
Revenue Growth61.10%
Profit Margin-22.60%
ROA-24.50%
P/B Ratio-58.9
Op. Cash Flow$-6354919
Free Cash Flow$-199612
Technical Analysis
TrendBearish
RSI51.1
Support$6.53
Resistance$8.49
MA 20$7.03
MA 50$7.78
MA 200$9.01
MACDBullish
VolumeIncreasing
Fear & Greed Index91.5
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-0.19
Volatility90.19%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.